Martha L Arango-Rodriguez
Overview
Explore the profile of Martha L Arango-Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pico O, Espinoza F, Cadiz M, Sossa C, Becerra-Bayona S, Salgado M, et al.
Cytotherapy
. 2024 Nov;
27(2):188-200.
PMID: 39503681
Background: Knee osteoarthritis (OA) is the most prevalent degenerative musculoskeletal disorder, which is particularly common in older population. While conventional treatments have limited effectiveness, the development of more effective therapeutic...
2.
Arango-Rodriguez M, Mateus L, Sossa C, Becerra-Bayona S, Solarte-David V, Vera M, et al.
Stem Cell Res Ther
. 2023 Aug;
14(1):221.
PMID: 37626416
Background: Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furthermore, patients with advanced...
3.
Arango-Rodriguez M, Solarte-David V, Becerra-Bayona S, Callegari E, Paez M, Sossa C, et al.
Cytotherapy
. 2022 Sep;
24(10):1035-1048.
PMID: 36084965
Background: Diabetes-related foot complications have been identified as the most common isolated cause of morbidity among patients with diabetes and the leading cause of amputation. Therefore, new strategies to stimulate...
4.
Lozano Navarro L, Chen X, Girata Viviescas L, Ardila-Roa A, Luna-Gonzalez M, Sossa C, et al.
Stem Cell Res Ther
. 2022 Jul;
13(1):345.
PMID: 35883198
Peripheral arterial disease is atherosclerotic occlusive disease of the lower extremity arteries and afflicts hundreds of millions of individuals worldwide. Its most severe manifestation is chronic limb-threatening ischemia (Petersen et...
5.
Solarte David V, Guiza-Arguello V, Arango-Rodriguez M, Sossa C, Becerra-Bayona S
Front Bioeng Biotechnol
. 2022 Mar;
10:821852.
PMID: 35252131
The absence or damage of a tissue is the main cause of most acute or chronic diseases and are one of the appealing challenges that novel therapeutic alternatives have, in...
6.
Becerra-Bayona S, Solarte V, Alviar Rueda J, Sossa C, Arango-Rodriguez M
Biologicals
. 2021 Nov;
75:37-48.
PMID: 34785135
Mesenchymal stem cells are a tool in cell therapies but demand a large cell number per treatment, for that, suitable culture media is required which contains fetal bovine serum (FBS)....
7.
Becerra-Bayona S, Solarte-David V, Sossa C, Mateus L, Villamil M, Pereira J, et al.
Endocrinol Diabetes Metab Case Rep
. 2020 Jul;
2020.
PMID: 32698128
Summary: Diabetic foot ulcer morbidity and mortality are dramatically increasing worldwide, reinforcing the urgency to propose more effective interventions to treat such a devastating condition. Previously, using a diabetic mouse...
8.
de Mayo T, Conget P, Becerra-Bayona S, Sossa C, Galvis V, Arango-Rodriguez M
PLoS One
. 2017 Jun;
12(6):e0177533.
PMID: 28594903
Mesenchymal stromal cells (MSCs) have shown to be a promising tool in cell therapies to treat different conditions. Several pre-clinical and clinical studies have proved that the transplantation of MSCs...
9.
Bruna F, Contador D, Conget P, Erranz B, Sossa C, Arango-Rodriguez M
Stem Cells Int
. 2016 Jun;
2016:1461648.
PMID: 27247575
Preclinical and clinical studies have shown that a therapeutic effect results from mesenchymal stromal cells (MSCs) transplant. No systematic information is currently available regarding whether donor age modifies MSC regenerative...
10.
Solarte V, Rosas J, Rivera Z, Arango-Rodriguez M, Garcia J, Vernot J
Biomed Res Int
. 2015 Nov;
2015:630179.
PMID: 26609531
Several short linear peptides derived from cyclic bovine lactoferricin were synthesized and tested for their cytotoxic effect against the oral cavity squamous-cell carcinoma (OSCC) cell lines CAL27 and SCC15. As...